Selective killing of leukaemia cells by antibody-toxin conjugates: Implications for autologous bone marrow transplantation

Keith A. Krolick, Jonathan W. Uhr, Ellen S. Vitetta

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

The recent development of tumour-reactive monoclonal antibodies has stimulated interest in their use in targeting toxic agents to tumour cells. One such approach involves the covalent coupling of tumour-reactive antibodies to the toxic peptide of the plant toxin, ricin. Such conjugates are highly effective in killing various tumour cells in vitro1-6. Here we have used the murine B-cell tumour, BCL1, in an adoptive transfer system capable of detecting 1-10 tumour cells, to demonstrate the effectiveness and specificity of an anti-immunoglobulin(Ig)-ricin A chain conjugate in deleting tumour cells from infiltrated murine bone marrow. We report that the transferred cells were able to repopulate the haematopoietic system of lethally irradiated mice and that in most mice the tumour did not recur. We discuss the implications of this approach for autologous bone marrow transplantation following supralethal tumour therapy.

Original languageEnglish (US)
Pages (from-to)604-605
Number of pages2
JournalNature
Volume295
Issue number5850
DOIs
StatePublished - 1982

Fingerprint

Immunotoxins
Autologous Transplantation
Bone Marrow Transplantation
Leukemia
Neoplasms
Ricin
Toxic Plants
Neoplasm Antibodies
Hematopoietic System
Adoptive Transfer
Poisons
Immunoglobulins
B-Lymphocytes
Bone Marrow
Monoclonal Antibodies
Peptides

ASJC Scopus subject areas

  • General

Cite this

Selective killing of leukaemia cells by antibody-toxin conjugates : Implications for autologous bone marrow transplantation. / Krolick, Keith A.; Uhr, Jonathan W.; Vitetta, Ellen S.

In: Nature, Vol. 295, No. 5850, 1982, p. 604-605.

Research output: Contribution to journalArticle

@article{a5dd9824051e427593ba3df12832a220,
title = "Selective killing of leukaemia cells by antibody-toxin conjugates: Implications for autologous bone marrow transplantation",
abstract = "The recent development of tumour-reactive monoclonal antibodies has stimulated interest in their use in targeting toxic agents to tumour cells. One such approach involves the covalent coupling of tumour-reactive antibodies to the toxic peptide of the plant toxin, ricin. Such conjugates are highly effective in killing various tumour cells in vitro1-6. Here we have used the murine B-cell tumour, BCL1, in an adoptive transfer system capable of detecting 1-10 tumour cells, to demonstrate the effectiveness and specificity of an anti-immunoglobulin(Ig)-ricin A chain conjugate in deleting tumour cells from infiltrated murine bone marrow. We report that the transferred cells were able to repopulate the haematopoietic system of lethally irradiated mice and that in most mice the tumour did not recur. We discuss the implications of this approach for autologous bone marrow transplantation following supralethal tumour therapy.",
author = "Krolick, {Keith A.} and Uhr, {Jonathan W.} and Vitetta, {Ellen S.}",
year = "1982",
doi = "10.1038/295604a0",
language = "English (US)",
volume = "295",
pages = "604--605",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "5850",

}

TY - JOUR

T1 - Selective killing of leukaemia cells by antibody-toxin conjugates

T2 - Implications for autologous bone marrow transplantation

AU - Krolick, Keith A.

AU - Uhr, Jonathan W.

AU - Vitetta, Ellen S.

PY - 1982

Y1 - 1982

N2 - The recent development of tumour-reactive monoclonal antibodies has stimulated interest in their use in targeting toxic agents to tumour cells. One such approach involves the covalent coupling of tumour-reactive antibodies to the toxic peptide of the plant toxin, ricin. Such conjugates are highly effective in killing various tumour cells in vitro1-6. Here we have used the murine B-cell tumour, BCL1, in an adoptive transfer system capable of detecting 1-10 tumour cells, to demonstrate the effectiveness and specificity of an anti-immunoglobulin(Ig)-ricin A chain conjugate in deleting tumour cells from infiltrated murine bone marrow. We report that the transferred cells were able to repopulate the haematopoietic system of lethally irradiated mice and that in most mice the tumour did not recur. We discuss the implications of this approach for autologous bone marrow transplantation following supralethal tumour therapy.

AB - The recent development of tumour-reactive monoclonal antibodies has stimulated interest in their use in targeting toxic agents to tumour cells. One such approach involves the covalent coupling of tumour-reactive antibodies to the toxic peptide of the plant toxin, ricin. Such conjugates are highly effective in killing various tumour cells in vitro1-6. Here we have used the murine B-cell tumour, BCL1, in an adoptive transfer system capable of detecting 1-10 tumour cells, to demonstrate the effectiveness and specificity of an anti-immunoglobulin(Ig)-ricin A chain conjugate in deleting tumour cells from infiltrated murine bone marrow. We report that the transferred cells were able to repopulate the haematopoietic system of lethally irradiated mice and that in most mice the tumour did not recur. We discuss the implications of this approach for autologous bone marrow transplantation following supralethal tumour therapy.

UR - http://www.scopus.com/inward/record.url?scp=0020486129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020486129&partnerID=8YFLogxK

U2 - 10.1038/295604a0

DO - 10.1038/295604a0

M3 - Article

C2 - 7035973

AN - SCOPUS:0020486129

VL - 295

SP - 604

EP - 605

JO - Nature

JF - Nature

SN - 0028-0836

IS - 5850

ER -